Table 3.
Study | Patient number | VTE number | Overall incidence (%) | Prophylaxis | Screening method | Risk factors |
---|---|---|---|---|---|---|
Montgomery et al.2 | 101 | 38 | 38 | P + IVCF | MRV | Time to surgery |
Stannard et al.27 | 107 | 15 | 14 | M | U + MRV | Age, time to surgery |
Steele et al.21 | 103 | 11 | 11 | P | U | High ISS, delayed use of LMWH |
*Kim et al.11 | 95 | 32 | 34 | N/A | CTV | Age, VS type fracture |
*Sen et al.5 | 56 | 15 | 26.8 | None | CTV | None |
*Wang et al.6 | 95 | 32 | 34 | N/A | Age, time to surgery | |
*Niikura et al.3 | 126 | 38 | 30 | M | U, CT (+) | Multiple fractures |
*Niikura et al.4 | 46 | 19 | 41 | M | U, CT (+) | N/A |
Lowe et al.20 | 750 | 10 | 1 | M + P | N/A | None |
VTE, venous thromboembolic event; P, pharmacological thromboprophylaxis; IVCF, inferior vena cava filter; M, mechanical thromboprophylaxis; MRV, magnetic resonance venography; U, ultrasonography; CTV, computed tomography venography; CT (+), computed tomography with contrast; ISS, injury severity score; LMWH, low molecular weight heparin; VS, vertical shear; N/A, not applicable.
*Studies reporting the incidence of VTE in Asian patients with pelvic and/or acetabular fracture.